asn008
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 14, 2019 (NCT03798561)
Timeline
Indications
Mechanism of action
SCN2A inhibitor
SCN1A inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05870865 | Phase 2 | May 3, 2023 | TrialSpark |
| NCT03798561 | Phase 1 | Jan 14, 2019 | Asana BioSciences |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Asana BioSciences | For profit | 1 | 1 | 1 | 2019 |
| TrialSpark | For profit | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1